DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
LHRH agonist
Gonadotropin-releasing hormone agonist
A gonadotropin-releasing hormone agonist (GnRH agonist, GnRH–A) is a synthetic peptide modeled after the hypothalamic neurohormone GnRH that interacts with the gonadotropin-releasing hormone receptor to elicit its biologic response, the release of the pituitary hormones FSH and LH. GnRH agonists are pregnancy category X drugs.
LHRH agonist - List of case studies
- Prostatic Adenocarcinoma
-
cancer. His current treatment consists of Estracyt and LHRH agonist. It is recommended to consider Chemotherapy as an another treatment ... ng/ml. Casodex 150 mg therefore suspended, treated with LHRH-analogue and Bicalutamide 50. November 2007 PSA 46.19 ng/ml reported. ...
- Drugs
-
L-leucovorin LAQ824 LASIX LBH589 LHRH agonist LHRH-A LIMPIDEX Labelled somatostatin analogues ...
- Prostatic adenocarcinoma – additional information
-
"second line" hormonal treatment, together with LHRH agonist that he currently takes. ... hormonal treatment. We do not stop the treatment with LHRH agonist ( Superfact Depot ) although the disease is already defined as ...
- Treatments
-
laser treatment L LCX intervention LHRH agonist LHRH agonists LHRH-A Labelled somatostatin analogues ...
- Hepatic metastases from prostatic adenocarcinoma
-
was undeniable. Therefore, an androgen block with LHRH agonists was suggested ( Decapeptyl 3.75 1 intramuscular vial for 28 ... at this stage is total hormonal ablation with LHRH agonist (injection of Suprefact Depot 9.9mg or Zoladex 10.8mg every 12 ...